Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/28/2023
Takeda China Expands Collaborations for Digital Healthcare Innovation ...
11/27/2023
CDE Solicits Comments on the Technical Guidelines for Application of D...
11/27/2023
AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...
11/27/2023
Coherus Sets Price of China-Made PD-1 Inhibitor Loqtorzi at a 20% Disc...
11/27/2023
Indian Pharma to Benefit amid Big Pharma's China De-Risking
11/27/2023
Over 1B Enrollees Signed Up BMI's Digital Code System Four Year After ...
11/27/2023
China's BMI Fund Tops CNY 2.6T in Revenue in First Ten Months of 202...
11/27/2023
Moderna Begins Work on Its mRNA China Plant
11/27/2023
CDE Solicits Comments on the Detailed Rules on Adding Pediatric Inform...
11/26/2023
Zhifei to Acquire Chenan to Expand into Metabolic Disease Drugs
11/26/2023
Dizal Strikes Derma Drug JV Deal with Wuxi High-tech Zone
11/26/2023
NHSA Issues New Doc to Strengthen and Enhance Drug Price and Tender Cr...
11/26/2023
CDE Issues the Guide to Compilation of Drug Package Inserts (Abbreviat...
11/24/2023
China Concludes Tendering Process of 9th VBP amid Reform to Improve ...
11/24/2023
CDE Solicits Comments on the Technical Guidelines for Application of D...
11/24/2023
Drug R&D and Product Registration News Digest 11/2023 (2)
11/24/2023
Recent Executive Moves
11/24/2023
China Gearing Up to Take on Pharmaceutical Giants, Drive Biotech Boom ...
11/24/2023
China Biopharma: Charting a Path to Value Creation (McKinsey)
11/23/2023
PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
11/23/2023
Myricx Concludes Global Licence Deal for WuXi Bio's Antibody
11/23/2023
CDE Solicits Comments on the Guidelines for BE Studies of Dydrogestero...
11/23/2023
CDE Solicits Comments on the Technical Guidelines for Safety Informati...
11/23/2023
State Council Approves the Draft Implementation Rules of the Patent L...
11/22/2023
Acrometa to Strengthen Biopharma Presence in China by Developing Co-Wo...
11/22/2023
Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
11/21/2023
MNCs Unveil Initiatives at CIIE to Deepen Connection with Chinese Pati...
11/21/2023
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differe...
11/21/2023
AstraZeneca and Usynova Strike Global License Deal for KRASG12D Inhib...
11/21/2023
Connect Bio and Simcere Pharma Announce Exclusive License Deal for Rad...
Page:
97
/
790
Total number of articles:
23678
:
[First]
[<<]
[95]
[96]
[97]
[98]
[99]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit